globes.co.il5h
Tal Zaks's Israeli startup targets rare genetic diseases
The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...
TMCnet6h
Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T ™) products for cancer and autoimmune disease, today ...